The $85 Million Bet That a DNA Scaffold Can Make Gene Therapy Re-Dosable

Code Biotherapeutics is trying to turn DNA into the FedEx network for genetic medicine. Its modular 3DNA scaffold promises bigger payloads, precise addresses and repeat delivery - but the public evidence is still preclinical.